tiprankstipranks
Renalytix AI Plc (GB:RENX)
LSE:RENX
Holding GB:RENX?
Track your performance easily

Renalytix AI (RENX) Share Price & Analysis

10 Followers

RENX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

16.11%0.05%83.84%
16.11% Insiders
0.05% Other Institutional Investors
83.84% Public Companies and
Individual Investors

RENX FAQ

What was Renalytix AI Plc’s price range in the past 12 months?
Renalytix AI Plc lowest share price was 6.50p and its highest was 74.90p in the past 12 months.
    What is Renalytix AI Plc’s market cap?
    Currently, no data Available
    When is Renalytix AI Plc’s upcoming earnings report date?
    Renalytix AI Plc’s upcoming earnings report date is Mar 27, 2025 which is in 94 days.
      How were Renalytix AI Plc’s earnings last quarter?
      Currently, no data Available
      Is Renalytix AI Plc overvalued?
      According to Wall Street analysts Renalytix AI Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Renalytix AI Plc pay dividends?
        Renalytix AI Plc does not currently pay dividends.
        What is Renalytix AI Plc’s EPS estimate?
        Renalytix AI Plc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Renalytix AI Plc have?
        Renalytix AI Plc has 331,206,020 shares outstanding.
          What happened to Renalytix AI Plc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Renalytix AI Plc?
          Currently, no hedge funds are holding shares in GB:RENX
          ---

          Renalytix AI Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Company Description

          Renalytix AI Plc

          Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
          ---

          RENX Earnings Call

          Q3 2024
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Arrayit
          Fulgent Genetics
          CareDx
          Renalytix AI
          QuidelOrtho
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis